## CPB: The Campbell's Company - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 0.69 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.6% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($28.40)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.00M) |
| Sells | 9 ($1.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Blackrock Inc.: 8.5% (+6.3%)
- Vanguard Group Inc: 7.9% (-2.2%)
- State Street Corpora: 3.7% (-7.1%)
- Invesco Ltd.: 2.7% (+42.6%)
- Beutel, Goodman & Co: 2.3% (-11.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.6% 5d) with bearish MACD, trend may be turning.
2. High short interest (18.8%, 3.9 days to cover): squeeze risk or crowded bearish bet.
3. Long-term trend broken: trading 12.0% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Insider selling cluster ($1.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.4B |
| Beta | -0.06 |
| 52W Range | $27.64 - $43.85 |
| Short Interest | 18.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 11.4 |
| Current P/E | 12.3 |
| YoY Growth | 7.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.0% to -4.6% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.6pp (needs >4.0% for momentum thesis). Underperforming sector by 4.5pp, stock-specific weakness. Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 41. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.62% (CS: 12) | Weak |
| RSI_14 | 41.0 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 0.972x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 0.880x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $29.84
- **Stop Loss:** $28.40 (4.8% risk)
- **Target:** $32.72 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 659
- **Position Value:** $19,664.56
- **Portfolio %:** 19.66%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.73 | $0.77 | +5.0% |
| 2025Q3 | $0.57 | $0.62 | +9.0% |
| 2025Q2 | $0.66 | $0.73 | +11.4% |
| 2025Q1 | $0.72 | $0.74 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*